| Page 901 | Kisaco Research
 

Nikolina Lauc

CO-Founder & CEO
GlycanAge

Nikolina Lauc

CO-Founder & CEO
GlycanAge

Nikolina Lauc

CO-Founder & CEO
GlycanAge
 

Karen Drexler

Angel Investor
Astia Angles

Karen Drexler

Angel Investor
Astia Angles

Karen Drexler

Angel Investor
Astia Angles
 

Ines O’Donovan

Co-Founder, Women for Longevity Club and Founder & Editor-in-Chief
Jeunessima Magazine

Ines O’Donovan

Co-Founder, Women for Longevity Club and Founder & Editor-in-Chief
Jeunessima Magazine

Ines O’Donovan

Co-Founder, Women for Longevity Club and Founder & Editor-in-Chief
Jeunessima Magazine
 

Betsy Bluestone

Managing Director
P&G Ventures

Betsy Bluestone

Managing Director
P&G Ventures

Betsy Bluestone

Managing Director
P&G Ventures
 

Asima Ahmad

Co-Founder and Chief Medical Officer
Carrot

Asima Ahmad

Co-Founder and Chief Medical Officer
Carrot

Asima Ahmad

Co-Founder and Chief Medical Officer
Carrot
 

Aliëtte van der Wal

Business Leader - Consumer Health Business Development
Philips

Aliëtte van der Wal

Business Leader - Consumer Health Business Development
Philips

Aliëtte van der Wal

Business Leader - Consumer Health Business Development
Philips
 
Clone of Phage Futures 2021
24-26 Feb 2021
Virtual Congress
Join us at the International Phage Futures Congress in 2021, as we create a virtual stage upon which to initiate all-important discussions & forge partnerships between key stakeholders from all over the world. Experts in their respective fields will discuss how to translate new phage-based applications into clinical studies & beyond.Discover how you can be at the forefront of the developing phage therapy market.Network & learn from established biotech companies, emerging start-ups, leading academics, global accelerator representatives, investment firms, international healthcare organisations & regulatory bodies. Among other topics, expect to hear & participate in:Advice on how to successfully navigate clinical trial progression to prove efficacy along with recent developments from leading biotechs in phage therapeutic trials targeting chronic & acute illnesses.Regulatory discussions between international governing bodies with region specific follow-up conversations with the experts.Insights into new fields for phage application, such as oncology, diagnostics & microbial gene therapy.Expert advice on how to find & secure financial investments.
 

Jens Eberlein

Technical Lead, Immuno-Oncology
LUMICKS

Jens Eberlein

Technical Lead, Immuno-Oncology
LUMICKS

Jens Eberlein

Technical Lead, Immuno-Oncology
LUMICKS